Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas: evidence from a meta-analysis
The aim of the present study was to determine whether circulating soluble CD23 (sCD23) was associated with B cells non-Hodgkin’s lymphomas (B-NHL). PubMed, EMBASE, and ISI Web of Science were extensively searched without language restriction. Data was extracted in a standardized data collection shee...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 May 2018
|
| In: |
Annals of hematology
Year: 2018, Jahrgang: 97, Heft: 8, Pages: 1317-1325 |
| ISSN: | 1432-0584 |
| DOI: | 10.1007/s00277-018-3349-y |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1007/s00277-018-3349-y
|
| Verfasserangaben: | Yi-shu Huang, Xiang Zhou, Zhi-fang Yang, Zheng-tao Lv |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1678632414 | ||
| 003 | DE-627 | ||
| 005 | 20220817000134.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191010s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00277-018-3349-y |2 doi | |
| 035 | |a (DE-627)1678632414 | ||
| 035 | |a (DE-599)KXP1678632414 | ||
| 035 | |a (OCoLC)1341245238 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Huang, Yi-shu |e VerfasserIn |0 (DE-588)1196808015 |0 (DE-627)167863185X |4 aut | |
| 245 | 1 | 0 | |a Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas |b evidence from a meta-analysis |c Yi-shu Huang, Xiang Zhou, Zhi-fang Yang, Zheng-tao Lv |
| 264 | 1 | |c 11 May 2018 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 10.10.2019 | ||
| 500 | |a Im Titel ist die Zahl "23" tiefer gestellt | ||
| 520 | |a The aim of the present study was to determine whether circulating soluble CD23 (sCD23) was associated with B cells non-Hodgkin’s lymphomas (B-NHL). PubMed, EMBASE, and ISI Web of Science were extensively searched without language restriction. Data was extracted in a standardized data collection sheet after two reviewers scanned studies independently. The association between sCD23 and NHL was indicated as odds ratio (OR) along with its related 95% confidence interval (95% CI). Meta-analysis was conducted via RevMan 5.3. A total of five studies, which included 964 B-NHL patients and 1243 matched controls without B-NHL, among which 257 were HIV-positive donors and 986 were general controls, were included in our study. Meta-analysis revealed a significant association between peripheral sCD23 level and B-NHL in HIV-positive samples (OR 1.66, 95% CI 1.25, 2.20; P = 0.0005) as well as the general population (OR 2.51; 95% CI 1.71, 3.86; P < 0.00001). Meta-analysis, stratified by sampling time prior to diagnosis, indicated potential HIV-NHL patients are 2.34-folds more likely to have higher blood sCD23 level, although this association is statistically meaningful only during 3-5 years prior to diagnosis (95% CI 1.27, 4.33). Subgroup analysis based on B-NHL type demonstrated a significant association between sCD23 level and diffuse large B cell lymphoma (DLBCL), chronic lymphocytic leukemia (CLL), and follicular lymphoma (FL). The findings of our study indicate a positive association of circulating sCD23 level and B-NHL risks and highlight the possibility of sCD23 as a predictive marker of B-NHL. However, to better understand the underlying mechanism, further studies are needed. | ||
| 650 | 4 | |a Meta-analysis | |
| 650 | 4 | |a Non-Hodgkin’s lymphomas | |
| 650 | 4 | |a Soluble CD23 | |
| 700 | 1 | |a Zhou, Xiang |d 1990- |e VerfasserIn |0 (DE-588)1153553961 |0 (DE-627)1015048404 |0 (DE-576)500292566 |4 aut | |
| 700 | 1 | |a Yang, Zhi-fang |e VerfasserIn |0 (DE-588)1196808201 |0 (DE-627)1678632082 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d Berlin : Springer, 1991 |g 97(2018), 8, Seite 1317-1325 |h Online-Ressource |w (DE-627)253389852 |w (DE-600)1458429-3 |w (DE-576)072283157 |x 1432-0584 |7 nnas |a Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas evidence from a meta-analysis |
| 773 | 1 | 8 | |g volume:97 |g year:2018 |g number:8 |g pages:1317-1325 |g extent:9 |a Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas evidence from a meta-analysis |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00277-018-3349-y |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20191010 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1153553961 |a Zhou, Xiang |m 1153553961:Zhou, Xiang |p 2 | ||
| 999 | |a KXP-PPN1678632414 |e 3521021939 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","display":"Huang, Yi-shu","roleDisplay":"VerfasserIn","given":"Yi-shu","family":"Huang"},{"roleDisplay":"VerfasserIn","display":"Zhou, Xiang","role":"aut","family":"Zhou","given":"Xiang"},{"roleDisplay":"VerfasserIn","display":"Yang, Zhi-fang","role":"aut","family":"Yang","given":"Zhi-fang"}],"title":[{"title_sort":"Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas","subtitle":"evidence from a meta-analysis","title":"Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas"}],"language":["eng"],"recId":"1678632414","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 10.10.2019","Im Titel ist die Zahl \"23\" tiefer gestellt"],"name":{"displayForm":["Yi-shu Huang, Xiang Zhou, Zhi-fang Yang, Zheng-tao Lv"]},"id":{"eki":["1678632414"],"doi":["10.1007/s00277-018-3349-y"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"11 May 2018"}],"relHost":[{"pubHistory":["62, 1 (Februrary 1991)-"],"titleAlt":[{"title":"Hematology"}],"part":{"pages":"1317-1325","issue":"8","year":"2018","extent":"9","volume":"97","text":"97(2018), 8, Seite 1317-1325"},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin’s lymphomas evidence from a meta-analysisAnnals of hematology","note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"],"recId":"253389852","language":["eng"],"title":[{"title":"Annals of hematology","subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie","title_sort":"Annals of hematology"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York","dateIssuedKey":"1991","publisher":"Springer","dateIssuedDisp":"1991-"}],"id":{"issn":["1432-0584"],"eki":["253389852"],"zdb":["1458429-3"]}}],"physDesc":[{"extent":"9 S."}]} | ||
| SRT | |a HUANGYISHUELEVATEDSO1120 | ||